1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Naloxone Market
2.3. Global Naloxone Market, By Route of Administration, 2025 (US$ Million)
2.4. Global Naloxone Market, By Dosage, 2025 (US$ Million)
2.5. Global Naloxone Market, By Sales Channel, 2025 (US$ Million)
2.6. Global Naloxone Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Naloxone Market: Competitive Analysis
3.1. Market Positioning of Key Naloxone Market Vendors
3.2. Strategies Adopted by Naloxone Market Vendors
4. Naloxone Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Naloxone Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Parenteral
5.3.2. Intranasal
5.3.3. Sublingual
6. Naloxone Market: By Dosage, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. 0.4mg/ml
6.3.2. 1mg/1 ml
6.3.3. 0.4 mg/0.4 ml
7. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Hospitals Pharmacy
7.3.2. Outpatient Retail Pharmacy
7.3.3. Online Pharmacy
7.3.4. Others
8. North America Naloxone Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
8.3. Naloxone Market: By Dosage, 2024-2034, USD (Million)
8.4. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
8.5. Naloxone Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
8.5.1.1.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
8.5.1.1.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
8.5.1.2.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
8.5.1.2.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
8.5.1.3.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
8.5.1.3.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9. UK and European Union Naloxone Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.3. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.4. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5. Naloxone Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.1.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.1.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.2.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.2.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.3.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.3.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.4.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.4.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.5.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.5.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
9.5.1.6.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
9.5.1.6.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10. Asia Pacific Naloxone Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.3. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.4. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5. Naloxone Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.1.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.1.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.2.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.2.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.3.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.3.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.4.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.4.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.5.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.5.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
10.5.1.6.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
10.5.1.6.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
11. Latin America Naloxone Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
11.3. Naloxone Market: By Dosage, 2024-2034, USD (Million)
11.4. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
11.5. Naloxone Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
11.5.1.1.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
11.5.1.1.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
11.5.1.2.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
11.5.1.2.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
11.5.1.3.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
11.5.1.3.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
12. Middle East and Africa Naloxone Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
12.3. Naloxone Market: By Dosage, 2024-2034, USD (Million)
12.4. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
12.5. Naloxone Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
12.5.1.1.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
12.5.1.1.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
12.5.1.2.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
12.5.1.2.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Naloxone Market: By Route of Administration, 2024-2034, USD (Million)
12.5.1.3.2. Naloxone Market: By Dosage, 2024-2034, USD (Million)
12.5.1.3.3. Naloxone Market: By Sales Channel, 2024-2034, USD (Million)
13. Company Profile
13.1. Kaleo, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Pfizer Inc.,
13.3. West Ward Pharmaceuticals
13.4. Amneal Pharmaceuticals
13.5. Sandoz
13.6. ADAPT Pharma
13.7. Mylan
13.8. Amphastar Pharmaceuticals
13.9. Other Notable Players
